Advanced Search

 

Study ID Status Title Patient Level Data
116669 Completed RLV116669, A Preference Study of Device Attributes Between Two Placebo Dry Powder inhalers; ELLIPTA and DISKUS, in Adult Subjects with Chronic Obstructive Pulmonary Disease
116672 Completed Use of the 24-Hour Restless Legs Syndrome (RLS) Symptom Diary to Assess RLS Augmentation with Gabapentin Enacarbil: An Integrated Analysis from Five Studies
116678 Completed A Randomised, Double-blind (Sponsor Unblinded), Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of GSK2269557 Administered in Addition to Standard of Care in Adult Subjects Diagnosed With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
116679 Completed A multi-centre, randomised, double-blind, placebo-controlled, dose ranging study to evaluate the safety and efficacy of GSK2586184 in patients with chronic plaque psoriasis Study Listed on ClinicalStudyDataRequest.com
116681 Completed A Phase I, Randomized, Single-Blind, Three-Period Cross-Over, Placebo-Controlled, Single Oral Dose, Dose-Escalation (Part 1), Fixed Sequence, and Repeat Dose (Part 2) Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of losmapimod in Healthy Japanese Subjects. Study Listed on ClinicalStudyDataRequest.com
116684 Active, Not Recruiting PGX6115: Genetic Effects on Different eltrombopag Exposure between Asians and Whites
116688 Completed Gabapentin Enacarbil in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome With and Without Severe Sleep Disturbance: an Integrated Analysis of Subjective and Novel Objective Sleep Endpoints from Two Studies
116689 Completed An integrated review to evaluate dose response of umeclidinium (GSK573719) administered once or twice daily in Subjects with COPD
116696 Completed Prevalence of patients infected with CCR5-tropic HIV-1 in Korea
116697 Completed Open-label study to evaluate the safety and immunogenicity of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults aged 50 years or older
116698 Completed A Single-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
116702 Terminated A First Time in Human Study Exploring Preliminary Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2618960 in Healthy Volunteers and Patients with Relapsing Remitting Multiple Sclerosis Study Listed on ClinicalStudyDataRequest.com
116703 Completed A 3 month single center randomized pilot study to evaluate the feasibility and effectiveness of a program that promotes wellness by enhancing daily activity in subjects with chronic obstructive pulmonary disease (COPD)
116704 Completed A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections Study Listed on ClinicalStudyDataRequest.com
116705 Completed Immunogenicity, safety and reactogenicity study of GSK Biologicals’ meningococcal conjugate vaccine (GSK134612) when co-administered with Boostrix® in healthy adolescents and young adults between 11 and 25 years of age
116706 Active, Not Recruiting Pooled analysis of the assessment of the association of lung function improvements on COPD related exacerbations and other endpoints
116707 Recruiting A post-marketing surveillance study of Duodart® (Dutasteride/Tamsulosin) in the treatment of Filipino patients with Benign Prostatic Hyperplasia (BPH)
116708 Completed PGx: Study of GSK2336805 in HAI115879, genotyping and phenotyping of HCV viral RNA from a Phase II study using 12 weeks of GSK2336805 in combination with pegylated interferon and ribavirin
116711 Completed A randomised, placebo-controlled, double-blind, repeat dose escalation study with GSK2126458 in patients with Idiopathic Pulmonary Fibrosis (IPF)
116713 Completed Effects of Medium-Chain Triglycerides on Cognitive Function in Older Subjects with Age-Related Cognitive Decline
116715 Completed A single-center, randomized, blinded, placebo-controlled two-part study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the Selective Androgen Receptor Modulator (SARM), GSK2849466, in single and repeat doses, with and without food, in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
116717 Completed Evaluating the control of COPD symptoms in patients treated with tiotropium bromide 18mcg once daily alone, ADOAIR 50/250mcg twice daily alone or ADOAIR 50/250mcg plus tiotropium bromide 18mcg
116722 Completed Long-term persistence of hepatitis B antibodies and immune response to a challenge dose of GSK Biologicals’ Hepatitis B Virus vaccine, Engerix™-B Kinder (SKF103860), in 15-16 years old adolescents, vaccinated in infancy with Engerix™-B Kinder
116723 Completed AN OPEN LABEL, BALANCED, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, SINGLE ORAL DOSE, BIOEQUIVALENCE STUDY OF METFORMIN 500 MG TABLETS MANUFACTURED BY SAVIPHARM J.S.C, VIETNAM AND GLUCOPHAGE® 500 MG TABLETS MANUFACTURED BY MERCK SANTE S.A.S.2, RUE DU PRESSOIR VERT-45400 SEMOY-FRANCE AND BE REGISTERED IN VIETNAM IN HEALTHY, ADULT, HUMAN MALE SUBJECTS UNDER FASTING CONDITION
116727 Completed The vaccine response and long-term antibody persistence of GSK Biologicals’ MenACWY-TT vaccine (GSK134612) administered as one dose at 6 years post-MenC primary vaccination in healthy subjects aged 12-18 months at primary vaccination

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.